Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox
OwnerJoseph Matthew Colacinoinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of treating smallpox and other poxvirus infections with a pharmaceutically effective amount of LY582563 or LY217896.
Claims2
A method of treating smallpox and other poxviruses in a mammalian patient in need thereof comprising administering a therapeutically effective dose of the compound 1,3,4-thiadiazole-cyanamide or a pharmaceutically acceptable salt or solvate thereof.
A method of treating smallpox and other poxviruses in a mammalian patient in need thereof comprising administering a therapeutically effective dose of the compound 2-amino-9-[2-[bis(2,2,2-trifluoroethyl)-phosphonylmethoxy]ethyl]-6-p-methoxyphenylthiopurine.
Dependencies are inferred from the claim text.